PTAB Isn’t Making CBM Reviews Any Easier For Challengers

Présentation


Alexander Ott, addressing the future of Patent Trial and Appeal Board review of covered business methods (CBMs), said, « It’s unclear if CBMs will be allowed to sunset in 2020, but it sort of seems like CBMs might go away with a whimper rather than continue to be used to the point where the program will be extended. » Mr. Ott doubted that what he called « also-ran » CBM dependent claims which aren’t critical to the patent will be allowed to continue.